المؤلفون: Singer M; Medical Center Ophthalmology Associates, San Antonio, Texas., Singh RP; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland, Ohio., Gibson A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Moini H; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Reed K; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Vitti R; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Du W; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Eichenbaum D; Retina Vitreous Associates of Florida, St. Petersburg, Florida. Electronic address: deichenbaum@rvaf.com.

المصدر: Ophthalmology [Ophthalmology] 2021 Nov; Vol. 128 (11), pp. 1657-1660. Date of Electronic Publication: 2021 May 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE

مواضيع طبية MeSH: Visual Acuity*, Angiogenesis Inhibitors/*administration & dosage , Ranibizumab/*administration & dosage , Receptors, Vascular Endothelial Growth Factor/*administration & dosage , Recombinant Fusion Proteins/*administration & dosage , Wet Macular Degeneration/*diagnosis, Aged ; Female ; Humans ; Intravitreal Injections ; Male ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Wet Macular Degeneration/physiopathology

المؤلفون: Ehlers JP; Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: ehlersj@ccf.org., Uchida A; Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA., Sevgi DD; Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA., Hu M; Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Reed K; Regeneron, Tarrytown, New York, USA., Berliner A; Regeneron, Tarrytown, New York, USA., Vitti R; Regeneron, Tarrytown, New York, USA., Chu K; Regeneron, Tarrytown, New York, USA., Srivastava SK; Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.

المصدر: American journal of ophthalmology [Am J Ophthalmol] 2021 Apr; Vol. 224, pp. 217-227. Date of Electronic Publication: 2020 Nov 28.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1891 (Electronic) Linking ISSN: 00029394 NLM ISO Abbreviation: Am J Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*therapeutic use , Diabetic Retinopathy/*drug therapy , Macular Edema/*drug therapy , Receptors, Vascular Endothelial Growth Factor/*therapeutic use , Recombinant Fusion Proteins/*therapeutic use , Subretinal Fluid/*metabolism , Visual Acuity/*physiology, Adult ; Aged ; Aged, 80 and over ; Diabetic Retinopathy/metabolism ; Diabetic Retinopathy/physiopathology ; Double-Blind Method ; Female ; Fluorescein Angiography ; Follow-Up Studies ; Humans ; Intravitreal Injections ; Laser Coagulation ; Macular Edema/metabolism ; Macular Edema/physiopathology ; Male ; Middle Aged ; Tomography, Optical Coherence ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Volatilization

المؤلفون: Ali F; Retina Center of Texas, Dallas, Texas., Kasi S; Retina Group of Washington, Alexandria, Virginia., Saroj N; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Baker K; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Thompson D; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Vitti R; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Berliner AJ; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Metzig C; Bayer Healthcare, Berlin, Germany., Ho AC; Wills Eye Hospital, Philadelphia, Pennsylvania; Thomas Jefferson University, Philadelphia, Pennsylvania; Mid Atlantic Retina, Philadelphia, Pennsylvania. Electronic address: acho@midatlanticretina.com.

المصدر: Ophthalmology. Retina [Ophthalmol Retina] 2020 Apr; Vol. 4 (4), pp. 452-454. Date of Electronic Publication: 2019 Dec 09.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-6530 (Electronic) Linking ISSN: 24686530 NLM ISO Abbreviation: Ophthalmol Retina Subsets: MEDLINE

مواضيع طبية MeSH: Visual Acuity*, Diabetic Retinopathy/*drug therapy , Macular Edema/*drug therapy , Receptors, Vascular Endothelial Growth Factor/*administration & dosage , Recombinant Fusion Proteins/*administration & dosage , Vitreous Detachment/*etiology, Adult ; Angiogenesis Inhibitors/administration & dosage ; Diabetic Retinopathy/complications ; Diabetic Retinopathy/diagnosis ; Fluorescein Angiography ; Fundus Oculi ; Humans ; Intravitreal Injections ; Macular Edema/diagnosis ; Macular Edema/etiology ; Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors ; Tomography, Optical Coherence ; Treatment Outcome ; Vitreous Detachment/diagnosis

المؤلفون: Terasaki H; Department of Ophthalmology, Nagoya University Hospital, Nagoya, Japan., Shiraki K; Department of Ophthalmology and Visual Sciences, Osaka City University, Osaka, Japan., Ohji M; Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan., Metzig C; Bayer AG, Berlin, Germany., Schmelter T; Bayer AG, Berlin, Germany., Zeitz O; Bayer AG, Berlin, Germany., Sowade O; Bayer AG, Berlin, Germany., Kobayashi M; Bayer Pharmaceuticals, Osaka, Japan., Vitti R; Regeneron Pharmaceuticals, Tarrytown, New York., Berliner A; Regeneron Pharmaceuticals, Tarrytown, New York., Shiraga F; Department of Ophthalmology, Okayama University Medical School, Okayama, Japan.

المصدر: Retina (Philadelphia, Pa.) [Retina] 2019 May; Vol. 39 (5), pp. 938-947.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8309919 Publication Model: Print Cited Medium: Internet ISSN: 1539-2864 (Electronic) Linking ISSN: 0275004X NLM ISO Abbreviation: Retina Subsets: MEDLINE

مواضيع طبية MeSH: Visual Acuity*, Diabetic Retinopathy/*drug therapy , Macula Lutea/*pathology , Macular Edema/*drug therapy , Receptors, Vascular Endothelial Growth Factor/*administration & dosage , Recombinant Fusion Proteins/*administration & dosage, Aged ; Diabetic Retinopathy/complications ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Follow-Up Studies ; Humans ; Intravitreal Injections ; Japan ; Macular Edema/etiology ; Male ; Middle Aged ; Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors ; Treatment Outcome

المؤلفون: Heier JS; Ophthalmic Consultants of Boston, Boston, Massachusetts., Korobelnik JF; Service d'ophtalmologie, CHU de Bordeaux, France; University Bordeaux, ISPED, F-33000 Bordeaux, Bordeaux, France; Inserm, U1219 - Bordeaux Population Health Research Center, F-33000 Bordeaux, France., Brown DM; Retina Consultants of Houston, Houston, Texas., Schmidt-Erfurth U; Medical University of Vienna, Vienna, Austria., Do DV; Ocular Imaging Research and Reading Center, Omaha, Nebraska., Midena E; Department of Ophthalmology, University of Padova, Padova, Italy., Boyer DS; Retina-Vitreous Associates Medical Group, Beverly Hills, California., Terasaki H; Nagoya University Hospital, Nagoya, Japan., Kaiser PK; Cole Eye Institute, Cleveland, Ohio., Marcus DM; Southeast Retina Center, Augusta, Georgia., Nguyen QD; Ocular Imaging Research and Reading Center, Omaha, Nebraska., Jaffe GJ; Department of Ophthalmology, Duke University, Durham, North Carolina., Slakter JS; Vitreous-Retina-Macula Consultants of New York, New York, New York., Simader C; Medical University of Vienna, Vienna, Austria., Soo Y; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Schmelter T; Bayer HealthCare, Berlin, Germany., Vitti R; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Berliner AJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Zeitz O; Bayer HealthCare, Berlin, Germany; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Metzig C; Bayer HealthCare, Berlin, Germany., Holz FG; Department of Ophthalmology, University of Bonn, Bonn, Germany. Electronic address: Frank.Holz@ukb.uni-bonn.de.

المصدر: Ophthalmology [Ophthalmology] 2016 Nov; Vol. 123 (11), pp. 2376-2385. Date of Electronic Publication: 2016 Sep 17.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE

مواضيع طبية MeSH: Visual Acuity*, Diabetic Retinopathy/*therapy , Laser Coagulation/*methods , Macula Lutea/*pathology , Macular Edema/*therapy , Receptors, Vascular Endothelial Growth Factor/*administration & dosage , Recombinant Fusion Proteins/*administration & dosage, Aged ; Diabetic Retinopathy/complications ; Diabetic Retinopathy/diagnosis ; Double-Blind Method ; Female ; Fluorescein Angiography ; Follow-Up Studies ; Fundus Oculi ; Humans ; Intravitreal Injections ; Macular Edema/diagnosis ; Macular Edema/etiology ; Male ; Middle Aged ; Retinal Vessels/pathology ; Retrospective Studies ; Time Factors ; Tomography, Optical Coherence ; Treatment Outcome ; Vascular Endothelial Growth Factor A/antagonists & inhibitors

المؤلفون: Nguyen QD; Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-9277, USA. qnguyen4@jhmi.edu, Campochiaro PA, Shah SM, Browning DJ, Hudson HL, Sonkin PL, Hariprasad SM, Kaiser PK, Slakter J, Haller JA, Do DV, Mieler W, Chu K, Ingerman A, Vitti R, Berliner AJ, Cedarbaum J

مؤلفون مشاركون: Clear-It 1 Investigators

المصدر: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2012 Dec; Vol. 28 (6), pp. 581-8. Date of Electronic Publication: 2012 Jul 09.

نوع المنشور: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Association For Ocular Pharmacology And Therapeutics Country of Publication: United States NLM ID: 9511091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7732 (Electronic) Linking ISSN: 10807683 NLM ISO Abbreviation: J Ocul Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Choroidal Neovascularization/*drug therapy , Macular Degeneration/*drug therapy , Receptors, Vascular Endothelial Growth Factor/*therapeutic use , Recombinant Fusion Proteins/*therapeutic use , Visual Acuity/*drug effects, Aged ; Aged, 80 and over ; Choroidal Neovascularization/pathology ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Fovea Centralis/drug effects ; Fovea Centralis/pathology ; Humans ; Intravitreal Injections ; Macular Degeneration/pathology ; Male ; Middle Aged ; Prospective Studies ; Receptors, Vascular Endothelial Growth Factor/administration & dosage ; Receptors, Vascular Endothelial Growth Factor/adverse effects ; Recombinant Fusion Proteins/administration & dosage ; Recombinant Fusion Proteins/adverse effects ; Treatment Outcome

المؤلفون: Schmidt-Erfurth, U, Kaiser, P, Korobelnik, J, Brown, D, Chong, V, Nguyen, Q, Ho, A, Ogura, Y, Simader, C, Jaffe, G, Slakter, J, Yancopoulos, G, Stahl, N, Vitti, R, Berliner, A, Soo, Y, Anderesi, M, Sowade, O, Zeitz, O, Norenberg, C, Sandbrink, R, Heier, J

المصدر: Ophthalmology. 121(1)

مصطلحات موضوعية: Male, genetic structures, Recombinant Fusion Proteins, Visual Acuity, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, eye diseases, Retina, Drug Combinations, Receptors, Vascular Endothelial Growth Factor, Treatment Outcome, Double-Blind Method, Ranibizumab, Intravitreal Injections, Retreatment, Wet Macular Degeneration, Humans, Female, Fluorescein Angiography, Tomography, Optical Coherence, Aged

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::47551c29d613d67683223f41f1f927a2
https://pubmed.ncbi.nlm.nih.gov/24084500